Team:UNIPV-Pavia/Calendar/July/settimana5
From 2010.igem.org
m (→July, 29th) |
|||
(11 intermediate revisions not shown) | |||
Line 33: | Line 33: | ||
<br> | <br> | ||
<html><p align="center"><font size="4"><b>JULY: WEEK 5</b></font></p></html><hr><br> | <html><p align="center"><font size="4"><b>JULY: WEEK 5</b></font></p></html><hr><br> | ||
+ | <html><a name="indice"/></html> | ||
==July, 26th== | ==July, 26th== | ||
Line 49: | Line 50: | ||
|} | |} | ||
- | Digestions were incubated at 37°C for 3 hours. A medium 1% agarose gel was prepared. I15-1 didn't give good | + | Digestions were incubated at 37°C for 3 hours. A medium 1% agarose gel was prepared. I15-1 didn't give good results, in fact many unwanted extra-bands were observed. For this reason, we decided not to perform ligation, but to sequence I15-1. An inoculum from glycerol stock for I15-1 was performed in 1ml LB+Amp, and incubated at 37°C 220rpm ON. Tomorrow I15-1 plasmide will be extracted with MiniPrep kit and I15-1 sample will be prepared for sequencing. |
Today we also screened 3 contaminants of MC1061 transformed with RING, incubated yesterday | Today we also screened 3 contaminants of MC1061 transformed with RING, incubated yesterday | ||
<table align='center'><tr><td> | <table align='center'><tr><td> | ||
- | [[Image:UNIPV10_I15_Extrabands.jpg|thumb| | + | [[Image:UNIPV10_I15_Extrabands.jpg|thumb|150px|center|4C5 (E-P) and I15-1 (E-P): extra-bands can be observed for I15-1]] |
</td><td> | </td><td> | ||
- | [[Image:UNIPV10_MC123_contaminants.jpg|thumb| | + | [[Image:UNIPV10_MC123_contaminants.jpg|thumb|150px|center|MC1-2-3 contaminants screening: no plasmid was observed]]</td></tr></table> |
<div align="right"><small>[[#indice|^top]]</small></div> | <div align="right"><small>[[#indice|^top]]</small></div> | ||
Line 62: | Line 63: | ||
==July, 27th== | ==July, 27th== | ||
- | Today we | + | Today we prepared I15-1 sample for sequencing. MiniPrep was performed on this culture and samples for both forward and reverse sequencing were prepared and sent to BMR genomics. |
Our self-inducible parts assembly goes on: we are ready to co-trasform I14_4C5, I16_4C5, I17_4C5, I18_4C5 and I19_4C5 in T9002 competent strain (home made). | Our self-inducible parts assembly goes on: we are ready to co-trasform I14_4C5, I16_4C5, I17_4C5, I18_4C5 and I19_4C5 in T9002 competent strain (home made). | ||
- | Since we noticed that our I7-3 and I8-5 glycerol stocks are not present in our freezer, we decided to prepare them today, starting from purified DNA (from MiniPrep) and tranforming it | + | Since we noticed that our I7-3 and I8-5 glycerol stocks are not present in our freezer, we decided to prepare them today, starting from purified DNA (from MiniPrep) and tranforming it again in TOP10. |
<table width='90%' border='1'> | <table width='90%' border='1'> | ||
- | <tr><td>'''Ligation name'''</td><td>'''E. coli strain''' </td><td> '''Resistance''' </td> | + | <tr> |
+ | <td>'''Ligation name'''</td><td>'''E. coli strain''' </td><td> '''Resistance''' </td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 79: | Line 81: | ||
</td> | </td> | ||
<td>Amp 100+Cm 12,5</td> | <td>Amp 100+Cm 12,5</td> | ||
- | </tr><tr><td> | + | </tr> |
+ | <tr><td> | ||
*I16_4C5-1= I16 (E-P) + pSB4C5 (E-P) | *I16_4C5-1= I16 (E-P) + pSB4C5 (E-P) | ||
</td> | </td> | ||
Line 86: | Line 89: | ||
</td> | </td> | ||
<td>Amp 100+Cm 12,5</td> | <td>Amp 100+Cm 12,5</td> | ||
- | </tr><tr><td> | + | </tr> |
+ | <tr><td> | ||
*I17_4C5-1= I17 (E-P) + pSB4C5 (E-P)</td> | *I17_4C5-1= I17 (E-P) + pSB4C5 (E-P)</td> | ||
<td> | <td> | ||
Line 92: | Line 96: | ||
</td> | </td> | ||
<td>Amp 100 + Cm 12,5</td> | <td>Amp 100 + Cm 12,5</td> | ||
- | </tr><tr><td> | + | </tr> |
+ | <tr><td> | ||
*I18_4C5-1= I18 (E-P) + pSB4C5 (E-P)</td> | *I18_4C5-1= I18 (E-P) + pSB4C5 (E-P)</td> | ||
<td> | <td> | ||
Line 98: | Line 103: | ||
</td> | </td> | ||
<td>Amp 100 + Cm 12,5</td> | <td>Amp 100 + Cm 12,5</td> | ||
- | </tr><tr><td> | + | </tr> |
+ | <tr><td> | ||
*I19_4C5-1= I19 (E-P) + pSB4C5 (E-P)</td> | *I19_4C5-1= I19 (E-P) + pSB4C5 (E-P)</td> | ||
<td> | <td> | ||
Line 104: | Line 110: | ||
</td> | </td> | ||
<td>Amp 100 + Cm 12,5</td> | <td>Amp 100 + Cm 12,5</td> | ||
- | </tr><tr><td> | + | </tr> |
+ | <tr><td> | ||
*I7-3</td> | *I7-3</td> | ||
<td> | <td> | ||
Line 111: | Line 118: | ||
<td>Amp 100</td> | <td>Amp 100</td> | ||
</tr> | </tr> | ||
- | + | <tr> | |
+ | <td> | ||
*I8-5</td> | *I8-5</td> | ||
<td> | <td> | ||
Line 125: | Line 133: | ||
* MC2: 34 ng/ul, digested with HindIII | * MC2: 34 ng/ul, digested with HindIII | ||
- | [[Image:UNIPV10_MC1_MC2_HindIII_and_unidigested_screening.jpg|thumb| | + | [[Image:UNIPV10_MC1_MC2_HindIII_and_unidigested_screening.jpg|thumb|150px|center|Screening for MC1 and MC2: digested with HindIII and undigested]] |
<div align="right"><small>[[#indice|^top]]</small></div> | <div align="right"><small>[[#indice|^top]]</small></div> | ||
==July, 28th== | ==July, 28th== | ||
+ | |||
+ | Today we received primers to modify PhaPs. We diluted primers to perform a PCR with them in order to mutagenize this BioBrick to get its prefix Standard/Silver compliant and suffix Silver compliant. | ||
<div align="right"><small>[[#indice|^top]]</small></div> | <div align="right"><small>[[#indice|^top]]</small></div> | ||
==July, 29th== | ==July, 29th== | ||
- | |||
- | |||
- | |||
Today we performed PCR in order to amplify the phasin PhaP (<partinfo>BBa_K208001</partinfo>). Out primers are built to eliminate the stop codon from phasin and to give it the prefix and suffix we desire: | Today we performed PCR in order to amplify the phasin PhaP (<partinfo>BBa_K208001</partinfo>). Out primers are built to eliminate the stop codon from phasin and to give it the prefix and suffix we desire: | ||
*PhaP with prefix compliant to the <html><a href="http://partsregistry.org/partsdb/scars.cgi"><b>10 Standard</b></a> and suffix compliant to the <a href="http://partsregistry.org/partsdb/scars.cgi"><b>Silver Standard</b></a></html> | *PhaP with prefix compliant to the <html><a href="http://partsregistry.org/partsdb/scars.cgi"><b>10 Standard</b></a> and suffix compliant to the <a href="http://partsregistry.org/partsdb/scars.cgi"><b>Silver Standard</b></a></html> | ||
Line 165: | Line 172: | ||
*1 ul of MilliQ (negative control). | *1 ul of MilliQ (negative control). | ||
Transformed cells have been plated on Cm 12,5 ug/ml agar plates and incubated overnight at 37°C. | Transformed cells have been plated on Cm 12,5 ug/ml agar plates and incubated overnight at 37°C. | ||
- | |||
- | |||
<div align="right"><small>[[#indice|^top]]</small></div> | <div align="right"><small>[[#indice|^top]]</small></div> | ||
Line 225: | Line 230: | ||
|[[Image:UNIPV10_I20.jpg|thumb|200px|center|I20 ligation plate]] || [[Image:UNIPV10_I21.jpg|thumb|200px|center|I21 ligation plate]] | |[[Image:UNIPV10_I20.jpg|thumb|200px|center|I20 ligation plate]] || [[Image:UNIPV10_I21.jpg|thumb|200px|center|I21 ligation plate]] | ||
|} | |} | ||
+ | |||
+ | <div align="right"><small>[[#indice|^top]]</small></div> | ||
+ | |||
<!-- table previous next week --> | <!-- table previous next week --> | ||
<br><br> | <br><br> | ||
Line 243: | Line 251: | ||
</tr> | </tr> | ||
</table> | </table> | ||
- | |||
- |
Latest revision as of 16:54, 24 October 2010
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|